Pau MG - Search Results

1

A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.

Marzio G, Kerkvliet E, Bogaards JA, Koelewijn S, De Groot A, Gijsbers L, Weverling GJ, Vogels R, Havenga M, Custers J, Pau MG, Guichoux JY, Lewis J, Goudsmit J. Marzio G, et al. Among authors: pau mg. Vaccine. 2007 Mar 8;25(12):2228-37. doi: 10.1016/j.vaccine.2006.12.011. Epub 2006 Dec 28. Vaccine. 2007. PMID: 17250936

2

Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

Rodríguez A, Mintardjo R, Tax D, Gillissen G, Custers J, Pau MG, Klap J, Santra S, Balachandran H, Letvin NL, Goudsmit J, Radosević K. Rodríguez A, et al. Among authors: pau mg. Vaccine. 2009 Oct 19;27(44):6226-33. doi: 10.1016/j.vaccine.2009.07.106. Epub 2009 Aug 15. Vaccine. 2009. PMID: 19686691

3

The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.

Radosevic K, Rodriguez A, Lemckert AA, van der Meer M, Gillissen G, Warnar C, von Eyben R, Pau MG, Goudsmit J. Radosevic K, et al. Among authors: pau mg. Clin Vaccine Immunol. 2010 Nov;17(11):1687-94. doi: 10.1128/CVI.00311-10. Epub 2010 Sep 8. Clin Vaccine Immunol. 2010. PMID: 20826614 Free PMC article.

4

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.

Shott JP, McGrath SM, Pau MG, Custers JH, Ophorst O, Demoitié MA, Dubois MC, Komisar J, Cobb M, Kester KE, Dubois P, Cohen J, Goudsmit J, Heppner DG, Stewart VA. Shott JP, et al. Among authors: pau mg. Vaccine. 2008 Jun 2;26(23):2818-23. doi: 10.1016/j.vaccine.2008.03.080. Epub 2008 Apr 16. Vaccine. 2008. PMID: 18455276

5

An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro.

Wunderlich K, van der Helm E, Spek D, Vermeulen M, Gecgel A, Pau MG, Vellinga J, Custers J. Wunderlich K, et al. Among authors: pau mg. J Gen Virol. 2014 Jul;95(Pt 7):1574-1584. doi: 10.1099/vir.0.064840-0. Epub 2014 Apr 24. J Gen Virol. 2014. PMID: 24764357

6

A rapid method for immunotitration of influenza viruses using flow cytometry.

Lonsdale R, Pau MG, Oerlemans M, Ophorst C, Vooys A, Havenga M, Goudsmit J, UytdeHaag F, Marzio G. Lonsdale R, et al. Among authors: pau mg. J Virol Methods. 2003 Jun 9;110(1):67-71. doi: 10.1016/s0166-0934(03)00102-2. J Virol Methods. 2003. PMID: 12757922

7

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.

Ophorst OJ, Radosević K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsmit J, Tsuji M. Ophorst OJ, et al. Among authors: pau mg. Infect Immun. 2006 Jan;74(1):313-20. doi: 10.1128/IAI.74.1.313-320.2006. Infect Immun. 2006. PMID: 16368986 Free PMC article.

8

A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Kostense S, Mommaas B, Hendriks J, Verhoeven M, Ter Haak M, Tirion F, Wiesken E, Pau MG, Radosevic K, Goudsmit J. Kostense S, et al. Among authors: pau mg. Clin Vaccine Immunol. 2011 May;18(5):776-82. doi: 10.1128/CVI.00547-10. Epub 2011 Mar 16. Clin Vaccine Immunol. 2011. PMID: 21411600 Free PMC article.

9

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.

Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J. Barouch DH, et al. Among authors: pau mg. Vaccine. 2011 Jul 18;29(32):5203-9. doi: 10.1016/j.vaccine.2011.05.025. Epub 2011 May 25. Vaccine. 2011. PMID: 21619905 Free PMC article.

10

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J. Barouch DH, et al. Among authors: pau mg. J Immunol. 2004 May 15;172(10):6290-7. doi: 10.4049/jimmunol.172.10.6290. J Immunol. 2004. PMID: 15128818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page